Skip to main content

Unplanned first-time admissions for cancer

Cancer survival in the United Kingdom is poorer than in many other European countries. For many patients with cancer, their diagnosis is first made when they are admitted to hospital as an emergency with complications of cancer. Hence, studying patients in whom cancer is diagnosed in this sway may provide information that can be used to improve the detection of cancer by the NHS. In a paper published recently in the British Journal of Cancer, Alex Bottle and colleagues from the Department of Primary Care & Public Health at Imperial College London examined patient and general practice characteristics associated with emergency (unplanned) first hospital admissions for cancer in England.

They reported that there were around 640,000 patients with a first-time admission for cancer, of which around 140,000 were unplanned, coming from 7957 GP practices. The unplanned proportion ranged from 14% (patients aged 15–44 years) to 45% (patients aged 85 years and older), with a large variation by patient characteristics such as ethnicity, deprivation, rurality and type of cancer. In unadjusted analyses, all patient and practice-level variables examined in the paper were statistically significant predictors of unplanned admissions. After adjustment, deprivation remained an important predictive factor for unplanned admission. Practices with higher total QOF (pay for performance) scores had lower rates of unplanned first-time admissions for cancer, as did practices that were able to offer more appointments within 48 hours. When cancer site was examined, cancer of the brain or CNS, pancreatic cancer and acute leukaemia had the highest risk of diagnosis during an unplanned admission relative to an elective admission.

Alex Bottle and colleagues have identified some patient and practice characteristics associated with a higher risk of first-time admission for cancer being unplanned. These findings could be used to help identify patients at high risk of late diagnosis of cancer. They also raise questions about the role of general practice organisation and access to primary care in improving the early detection of cancer. The article was featured by a number of organisations and newspaper, including Cancer Research UK and the Daily Mail.

Comments

Popular posts from this blog

Improving discharge planning in NHS hospitals

Factors that need to be considered in discharge planning that have been identified in previous projects include:

Ensuring that discharge arrangements are discussed with patients, family members and carers; and that they are given a copy of the discharge summary.Adequate coordination between the hospital, community health services, general practices, and the providers of social care services.There is a follow-up after discharge of patients at high risk of complications or readmission - either in person or by telephone - to ensure that the discharge arrangements are working well. Medicines reconciliation is carried out. This is the process of verifying patient medication lists at a point-of-care transition, such as hospital discharge, to identify which medications have been added, discontinued, or changed from pre-admission medication lists.Ensuring that any outstanding test results at discharge are obtained and passed on to primary care teams; and ensuring there are clear arrangements …

Can GPs issue private prescriptions to NHS patients?

The NHS prescription charge in England is currently £8.40 per item. At this level, many commonly prescribed drugs will cost less than the prescription charge and so some NHS patients may occasionally ask if they can have a private prescription rather than an NHS prescription.

In the past, some GPs have been advised that they could issue both an NHS FP10 and a private prescription, and let the patient decide which to use. But the British Medical Association's General Practice Committee has obtained legal advice that said under the current primary care contract, GPs in England may not issue a private prescription alongside or as an alternative to an NHS FP10 prescription. In any consultation where a GP needs to issue an FP10, the concurrent issue of a private prescription would be a breach of NHS regulations.

The issuing of a private prescription in such circumstances could also be seen as an attempt to deprive the NHS of the funds it would receive from the prescription charge. Fur…

What impact will Brexit have on the UK's life sciences sector?

On Thursday 3 November 2016, I spoke at a seminar at the Imperial College Business School on the topic of the impact of Brexit on the UK's life sciences sector (the NHS, universities, and pharmaceutical and biomedical companies). I emphasised the important role played in the life sciences sector by EU-trained professionals and the need to ensure that the UK continued to attract highly-qualified professionals to work, for example, in our National Health Service. I also discussed the need to increase spending on research and development to ensure that the UK remained a world leader in the biomedical industry. The other speakers at the seminar were Andrew Lansley (former Secretary of State for Health) and Richard Phillips (Director of Healthcare Policy at the Association of British Healthcare industries). The event was chaired by Andrew Brown. A copy of my talk can be viewed on Slideshare.